CALPAIN WAS ORIGINALLY CHARACTERIZED AS A calciumactivated neutral cysteine endopeptidase (EC 3.4.22.17) ubiquitously distributed in all animal cells examined thus far (1-3). Calpain now forms a family consisting of at least six distinctmembers (4-6). The family can be divided into two groups on the basis of distribution -ubiquitous and tissuespecific. Discovery of the novel tissue-specific members calls for caution in specifying which of the isozymes is being dealt with in individual studies.However, our current knowledge about the enzymological and biologicalproperties of calpain applies only to the ubiquitous isozymes, i-calpain and mcalpain (or calpain I and II, respectively profileis similar to those of the other ubiquitous isozymes thus far identified.
The expression level of this isozyme is comparable to those of the others.The detailsof itsstructure and expression will be described elsewhere.
Tissue-specific calpain
The newly discovered calpain isozymes, termed n-calpain, have similar but distinct structures (Fig. 1 
MODE OF ACTION

Limited proteolysis
The nature of calpain-catalyzed proteolysis is not digestive; it usually proceeds in a limited manner and resultsin alteration, rather than simple destruction, of the substrate proteins.A typicalexample is the case of protein kinase C iso- zymes as substrates,which are converted by calpain (both tand rn-types)to activeforms, as schematically shown in Fig.  2 (13) .Limited proteolysisat the hinge region between the regulatory (inhibitory) and catalytic domains of protein kinase C produces an active fragment, the activity of which is independent of cofactors such as phospholipids and phorbolester normally required for activation of the intact molecule.
The were examined only in test-tubeexperiments using purified calpain, conditions that do not necessarily reflect the actual in vivo processes.
ACTIVATION MECHANISM
Autolytic transition
Suzuki et al.(16) first described that chicken calpain undergoes autolysisquickly in the presence of sufficientcalcium and that autolysis lowers the calcium concentration required for itsproteolyticactivityto arise.Close examination of the kinetics of this process of mammalian t-calpain indicates that autolysis of the catalytic 80K and then of the 30 K subunit first occurs, followed by substrate proteolysis as depicted in Fig. 3 (17) .Therefore, subunit autolysisseems to be an important early event in the intramolecular activation process of this protease. This autolytic phenomenon can be used as an indicative hallmark in observing the initiation of calpain action. We first developed a set of such antibodies for the pre-and postautolysis forms of -calpain using synthetic peptides as shown in Fig. 4 (17) REVIEWS the suppressive effectsof inhibitorson postischemic damage (33). Based on the knowledge that fodrin is the major calpain substrate undergoing proteolysis in hippocampus immediately after transient forebrain ischemia followed by reperfusion (31), we developed an antibody exclusively specific for the proteolyzed form of fodrin and analyzed the process in spatial and chronological terms as shown in Fig. 5 (32) .
The results indicate that transient ischemia induced at least two distinct phases of fodrin proteolysis in hippocampus:
an early phase in molecular layer and in stratum oriens of CA3 and CAl sectors within 15 mm (Fig. B, C) , and a late, drastic and persistent phase in the entire CAl after 4-24 h (Fig. 5D) . The time lag between these early and late phases suggests that complex multiple events are involved during this period and that the early phase may be one of the initial steps triggering the cascade. Because major observable neuronal degeneration starts only 2-3 days after the ischemic shock mainly in CAl sector (35), the delayed phase of proteolysis seems be more directly involved in the death of neurons. The major vulnerable neurons, pyramidal cells in CAl, showed relatively weak immunoreactivity to proteolyzed fodrin compared with the surrounding cells until they actually started to degenerate (Fig. 5D ), indicating that additional steps after proteolysis may be required to achieve the de- 
